• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    11/1/23 1:59:52 PM ET
    $AIZ
    $ALDX
    $APO
    $ASTE
    Property-Casualty Insurers
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AIZ alert in real time by email

    Gainers

    • Cellectis S.A. (NASDAQ:CLLS) shares jumped 136% to $2.2799. Cellectis reported strategic collaboration and investment agreements with AstraZeneca. Cellectis also presented pre-clinical data on multi-armored allogeneic MUC1-CAR T-cells targeting triple-negative breast cancer at the Society for Immunotherapy of Cancer 38th Annual Meeting.
    • Patriot Transportation Holding, Inc. (NASDAQ:PATI) climbed 104.8% to $15.73. Patriot Transportation announced an agreement under which United Petroleum Transports will acquire all of the outstanding shares of Patriot common stock for $16.26 per share in cash.
    • Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) gained 33% to $2.2780. Aldeyra Therapeutics entered into an exclusive option agreement with AbbVie Inc.
    • ShiftPixy, Inc. (NASDAQ:PIXY) climbed 30% to $6.82.
    • Monopar Therapeutics Inc. (NASDAQ:MNPR) shares rose 29% to $0.5782. Monopar presented data showing tumor reduction benefit of camsirubicin from ongoing Phase 1b in patients with advanced soft tissue sarcoma at the 2023 Connective Tissue Oncology Society Annual Meeting.
    • TG Therapeutics, Inc. (NASDAQ:TGTX) climbed 26.8% to $9.80 following third-quarter results.
    • MSP Recovery, Inc. (NASDAQ:LIFW) gained 25% to $3.08. On Monday, the company announced that it is in compliance with all applicable Nasdaq listing standards.
    • ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) climbed 20% to $0.0984. ZyVersa Therapeutics announced publication in molecular neurobiology reinforcing data demonstrating that inflammasome ASC inhibitor IC 100 attenuates the inflammatory response causing neuronal damage in multiple sclerosis model.
    • EUDA Health Holdings Limited (NASDAQ:EUDA) rose 18.6% to $1.02.
    • GDEV Inc. (NASDAQ:GDEV) shares gained 16.2% to $2.35 after falling 11% on Tuesday.
    • Maison Solutions Inc. (NASDAQ:MSS) climbed 14.5% to $6.31.
    • Generac Holdings Inc. (NYSE:GNRC) gained 13.7% to $95.60 following upbeat earnings.
    • Mercury General Corporation (NYSE:MCY) gained 13.5% to $35.04 following quarterly results.
    • Davis Commodities Limited (NASDAQ:DTCK) rose 13.4% to $4.1850.
    • Newmark Group, Inc. (NASDAQ:NMRK) gained 13.4% to $6.44 following strong quarterly results.
    • The Scotts Miracle-Gro Company (NYSE:SMG) rose 11.8% to $49.70 following upbeat results.
    • Mercurity Fintech Holding Inc. (NYSE:MFH) surged 11.4% to $0.9950.
    • Garmin Ltd. (NYSE:GRMN) gained 10.4% to $113.16 after the company posted upbeat third-quarter results and raised FY23 guidance.
    • Frontdoor, Inc. (NASDAQ:FTDR) climbed 10.2% to $31.89 following strong results.
    • Assurant, Inc. (NYSE:AIZ) rose 10.2% to $164.09 following third quarter results.
    • Sientra, Inc. (NASDAQ:SIEN) shares climbed 10.1% to $0.7049. Sientra shares fell 56% on Tuesday after the company withdrew its FY23 guidance and reported interim third-quarter financial results.
    • Apollo Global Management, Inc. (NYSE:APO) gained 10% to $85.17 after reporting third-quarter results.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) shares rose 9% to $1.34 after the company reported third-quarter financial results and announced a share repurchase program.
    • The Chefs' Warehouse, Inc. (NASDAQ:CHEF) gained 9% to $20.74 following strong sales.

    Losers

    • WeWork Inc. (NYSE:WE) shares dipped 51.5% to $1.1050 following reports that the company is nearing bankruptcy.
    • CohBar, Inc. (NASDAQ:CWBR) fell 48.2% to $0.91. CohBar said on Nov. 1, it got termination notice from Morphogenesis, effective Nov. 1 and merger agreement was terminated in accordance with terms.
    • IRIDEX Corporation (NASDAQ:IRIX) fell 44.2% to $1.83. Iridex has withdrawn its previously announced annual guidance for 2023 and plans to provide additional information during its third-quarter earnings release based on the information available at that time.
    • Tempo Automation Holdings, Inc. (NASDAQ:TMPO) shares fell 37.8% to $0.0516 after dipping 30% on Tuesday.
    • Paycom Software, Inc. (NYSE:PAYC) fell 37.2% to $153.96. Paycom Software reported worse-than-expected third-quarter sales results and issued FY23 revenue guidance below estimates.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) fell 30% to $0.5205.
    • MasTec, Inc. (NYSE:MTZ) fell 23.2% to $45.63 following weak sales.
    • Lumen Technologies, Inc. (NYSE:LUMN) dipped 23.2% to $1.1200 following weak earnings.
    • Astec Industries, Inc. (NASDAQ:ASTE) declined 21.6% to $31.40 following downbeat results.
    • Motus GI Holdings, Inc. (NASDAQ:MOTS) fell 22% to $0.4678. Motus GI said 1-for-15 reverse stock split, will begin trading on split-adjusted basis Nov. 2.
    • The Estée Lauder Companies Inc. (NYSE:EL) dipped 20.5% to $102.35 following its first quarter results and lackluster outlook.
    • G1 Therapeutics, Inc. (NASDAQ:GTHX) fell 18.8% to $1.3397 following weak results.
    • Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares fell 18.2% to $0.4825 after the company reported topline results from Phase 2 proof-of-concept study of TNX-601 ER for the treatment of major depressive disorder.
    • Conduent Incorporated (NASDAQ:CNDT) dropped 17% to $2.6490 following weak earnings.
    • Yum China Holdings, Inc. (NYSE:YUMC) shares fell 16.9% to $43.67 after the company reported worse-than-expected financial results for its third quarter.
    • Match Group, Inc. (NASDAQ:MTCH) declined 16.2% to $29.00 after reporting third-quarter results and issuing fourth-quarter guidance.
    • Big 5 Sporting Goods Corporation (NASDAQ:BGFV) shares fell 14.6% to $6.02 after the company reported weaker-than-expected results for its third quarter.
    • Extreme Networks, Inc. (NASDAQ:EXTR) dipped 14.6% to $17.62 after the company reported first-quarter financial results and issued second-quarter guidance below estimates.
    • Bally's Corporation (NYSE:BALY) fell 14.4% to $7.81 following downbeat results.
    • Silicon Laboratories Inc. (NASDAQ:SLAB) fell 14.2% to $79.13 after the company reported third quarter financial results and issued fourth-quarter guidance.
    • Fresh Del Monte Produce Inc. (NYSE:FDP) declined 13.3% to $21.67 following downbeat results.
    • Puyi Inc. (NASDAQ:PUYI) fell 12.7% to $6.29.
    • TPG RE Finance Trust, Inc. (NYSE:TRTX) declined 12.3% to $4.83 following weak results.
    • SunCoke Energy, Inc. (NYSE:SXC) fell 11.7% to $8.40 following third-quarter results.
    • Paylocity Holding Corporation (NASDAQ:PCTY) dropped 10% to $161.41.
    • Canada Goose Holdings Inc. (NYSE:GOOS) dipped 10% to $9.99 following quarterly results.
    • SiteOne Landscape Supply, Inc. (NYSE:SITE) fell 9.7% to $124.32 following weak earnings.
    • Unum Group (NYSE:UNM) fell 8.3% to $44.82 following weak sales.
    • SunPower Corporation (NASDAQ:SPWR) fell 7.8% to $3.9350 following quarterly results.
    • BAIYU Holdings, Inc. (NASDAQ:BYU) fell 7.7% to $1.9201 after dipping 19% on Tuesday.
    • Synaptics Incorporated (NASDAQ:SYNA) fell 7% to $77.90.

    Now Read This: Ethereum Falls Below $1,800 Following ADP Report; Gala Becomes Top Loser

    Get the next $AIZ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIZ
    $ALDX
    $APO
    $ASTE

    CompanyDatePrice TargetRatingAnalyst
    Aldeyra Therapeutics Inc.
    $ALDX
    3/18/2026$2.00Buy → Neutral
    H.C. Wainwright
    Generac Holdlings Inc.
    $GNRC
    3/12/2026$237.00Buy → Neutral
    Citigroup
    TPG RE Finance Trust Inc.
    $TRTX
    3/12/2026$10.00Mkt Perform → Mkt Outperform
    Citizens
    Frontdoor Inc.
    $FTDR
    3/2/2026$67.00Sell → Neutral
    Goldman
    MasTec Inc.
    $MTZ
    3/2/2026$225.00 → $320.00Buy
    TD Cowen
    Apollo Global Management Inc. (New)
    $APO
    2/24/2026$142.00Sector Perform
    RBC Capital Mkts
    Garmin Ltd.
    $GRMN
    2/19/2026$252.00Underweight → Equal-Weight
    Morgan Stanley
    Cellectis S.A.
    $CLLS
    2/17/2026$7.00Buy
    Jefferies
    More analyst ratings

    $AIZ
    $ALDX
    $APO
    $ASTE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Dizon Romeo R bought $1,399 worth of shares (1,110 units at $1.26), increasing direct ownership by 0.93% to 121,000 units (SEC Form 4)

    4 - IRIDEX CORP (0001006045) (Issuer)

    3/9/26 1:05:37 PM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Mikhalevsky Andrei Alexander bought $27,650 worth of shares (5,000 units at $5.53), increasing direct ownership by 250% to 7,000 units (SEC Form 4)

    4 - SunCoke Energy, Inc. (0001514705) (Issuer)

    3/2/26 3:28:45 PM ET
    $SXC
    Steel/Iron Ore
    Industrials

    Senior Vice President Hardesty Phillip Michael bought $72,872 worth of shares (12,500 units at $5.83), increasing direct ownership by 4% to 298,677 units (SEC Form 4)

    4 - SunCoke Energy, Inc. (0001514705) (Issuer)

    2/26/26 3:02:42 PM ET
    $SXC
    Steel/Iron Ore
    Industrials

    $AIZ
    $ALDX
    $APO
    $ASTE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (ORIG-1) with active ingredient UBLITUXIMAB has changed to 'Approval' on 12/28/2022. Application Category: BLA, Application Number: 761238, Application Classification:

    12/28/22 12:54:09 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for COSELA

    Submission status for G1 THERAPEUTICS INC's drug COSELA (ORIG-1) with active ingredient TRILACICLIB DIHYDROCHLORIDE has changed to 'Approval' on 02/12/2021. Application Category: NDA, Application Number: 214200, Application Classification: Type 1 - New Molecular Entity

    2/16/21 4:31:16 PM ET
    $GTHX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIZ
    $ALDX
    $APO
    $ASTE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Lim Ai Imm

    3 - DAVIS COMMODITIES Ltd (0001949478) (Issuer)

    3/19/26 11:28:27 AM ET
    $DTCK
    Farming/Seeds/Milling
    Industrials

    SEC Form 3 filed by new insider Leck Li Peng

    3 - DAVIS COMMODITIES Ltd (0001949478) (Issuer)

    3/19/26 11:27:36 AM ET
    $DTCK
    Farming/Seeds/Milling
    Industrials

    SEC Form 3 filed by new insider Lee Abbie Jillia

    3 - DAVIS COMMODITIES Ltd (0001949478) (Issuer)

    3/19/26 11:27:04 AM ET
    $DTCK
    Farming/Seeds/Milling
    Industrials

    $AIZ
    $ALDX
    $APO
    $ASTE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Aldeyra Therapeutics downgraded by H.C. Wainwright with a new price target

    H.C. Wainwright downgraded Aldeyra Therapeutics from Buy to Neutral and set a new price target of $2.00

    3/18/26 8:20:05 AM ET
    $ALDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Generac downgraded by Citigroup with a new price target

    Citigroup downgraded Generac from Buy to Neutral and set a new price target of $237.00

    3/12/26 8:46:53 AM ET
    $GNRC
    Metal Fabrications
    Consumer Discretionary

    TPG RE Finance Trust upgraded by Citizens with a new price target

    Citizens upgraded TPG RE Finance Trust from Mkt Perform to Mkt Outperform and set a new price target of $10.00

    3/12/26 8:41:32 AM ET
    $TRTX
    Real Estate Investment Trusts
    Real Estate

    $AIZ
    $ALDX
    $APO
    $ASTE
    SEC Filings

    View All

    Tonix Pharmaceuticals Holding Corp. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K - Tonix Pharmaceuticals Holding Corp. (0001430306) (Filer)

    3/18/26 6:01:48 AM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GDEV Inc.

    6-K - GDEV Inc. (0001848739) (Filer)

    3/17/26 5:23:05 PM ET
    $GDEV
    EDP Services
    Technology

    SEC Form 10-Q filed by Maison Solutions Inc.

    10-Q - Maison Solutions Inc. (0001892292) (Filer)

    3/17/26 5:07:18 PM ET
    $MSS
    Food Chains
    Consumer Staples

    $AIZ
    $ALDX
    $APO
    $ASTE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Used Cars Still Dominate the Market; Prices Near $26,000

    With nearly 37 million used vehicles sold annually — more than double new-car sales — Mercury Insurance shares smart buying tips as shoppers hunt for valueLOS ANGELES, March 19, 2026 /PRNewswire/ -- Used-car shoppers are entering a market that has changed dramatically since the pandemic, with higher prices, tighter inventories and stronger demand pushing many drivers toward the pre-owned market. Mercury Insurance (NYSE/NYSE Texas: MCY) is helping consumers navigate the process with guidance on vehicle safety, history reports and insurance considerations before making a purchase.The typical used vehicle now sells for about $26,000 nationwide, and affordable models under $15,000 can be difficu

    3/19/26 12:00:00 PM ET
    $MCY
    Property-Casualty Insurers
    Finance

    Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%

    HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announces the presentation of a new health economics study evaluating the economic impact of earlier detection and therapeutic management of LM using the CNSide cerebrospinal fluid (CSF) assay. The cost-of-care analysis suggests that earlier LM diagnosis and therapeutic management enabled by CNSide may reduce overall LM-related healthcare costs by approximately 40%, primarily through earlier therapeutic intervention, improved treatment precisio

    3/19/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million

    NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. ("TG" or "the Company"), (NASDAQ:TGTX), today announced that it has entered into a new five-year, $750 million senior secured credit facility with funds managed by Blue Owl Capital ("Blue Owl"). As part of the transaction, the Company will repay its outstanding $250 million senior secured credit facility, resulting in a net raise of $500 million in non-dilutive capital. The new facility also provides for up to an additional $250 million of incremental capital, for a total facility size of up to $1 billion, available at the mutual discretion of TG and Blue Owl. In connection with the new facility, the Company's Board of Dir

    3/19/26 7:30:00 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIZ
    $ALDX
    $APO
    $ASTE
    Leadership Updates

    Live Leadership Updates

    View All

    The $17 Billion Solar Maintenance Market Just Got a New Player From the Defense Sector

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this article: VisionWave Holdings (NASDAQ:VWAV), First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SunPower (NASDAQ:SPWR), SolarEdge Technologies (NASDAQ:SEDG) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) subsidiary SolarDrone has acquired a 51% controlling interest in Junko Solar, an Israeli solar panel maintenance and cleaning company, and appointed its founder Amos Cohen as SolarDrone CEO.The global solar panel operation and maintenance market is valued at $17 billion in 2026 and projected to reach nearly $60 billion by 2035, growing at a 13.3% CAGR[1].First Solar inaugurated a $1.1 billion AI-enabled manuf

    3/17/26 9:00:00 AM ET
    $ENPH
    $FSLR
    $SEDG
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    Dennis Howard Joins Frontdoor Board of Directors

    Global executive brings wealth of knowledge and expertise in information technology, cybersecurity, operations and innovation Frontdoor, Inc. (NASDAQ:FTDR), the nation's leading provider of home warranties and new home builder warranties, today announced that its board unanimously approved the election of Dennis Howard as a director and appointed him as a member of the Audit Committee, effective today. "We are thrilled to welcome Dennis to Frontdoor's board," said Bill Cobb, Frontdoor's Chairman and Chief Executive Officer. "Dennis brings over 30 years of experience in information technology and cybersecurity across several consumer-focused businesses. He possesses a deep understanding

    3/17/26 7:45:00 AM ET
    $FTDR
    Diversified Commercial Services
    Consumer Discretionary

    Lumen Technologies Announces Board Chair Transition, New Director Nominee and Executive Role Expansions

    Board Chair Mike Glenn and Director Hal Jones to Retire at 2026 Annual Meeting; General Kevin P. Chilton Named Next Chair Bain & Company Partner Michael Collins Nominated to Join Board Enhances Leadership Structure to Support Growth Phase of Transformation Lumen Technologies, Inc. ("Lumen") (NYSE: LUMN) today announced that Mike Glenn, Chair of Lumen's Board of Directors (the "Board"), and Hal Stanley Jones, a director and Chair of the Audit Committee, have advised the Board that they will retire and not stand for re-election at Lumen's 2026 Annual Meeting of Shareholders (the "Annual Meeting"). This press release features multimedia. View the full release here: https://www.businessw

    3/17/26 7:30:00 AM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    $AIZ
    $ALDX
    $APO
    $ASTE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Monopar Therapeutics Inc.

    SC 13D/A - Monopar Therapeutics (0001645469) (Subject)

    12/17/24 5:01:42 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Paycom Software Inc.

    SC 13D/A - Paycom Software, Inc. (0001590955) (Subject)

    12/13/24 7:06:11 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    $AIZ
    $ALDX
    $APO
    $ASTE
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Monopar Therapeutics Inc. on Jun 21 Indicate?

    Monopar Therapeutics Inc. has recently seen notable insider activity, with Chief Operating Officer Cittadine Andrew purchasing $25,574 worth of shares on June 21st, 2024. This purchase, comprising 32,508 units at $0.79, increased Cittadine's direct ownership by 21% to 186,132 units as reported in the SEC Form 4. When analyzing this transaction alongside other recent insider activities within the company, interesting patterns and trends start to emerge. Looking back, Cittadine Andrew has been consistently adding to his position in Monopar Therapeutics Inc. over the past few months, showcasing a strong conviction in the company's future prospects. On May 31st, Cittadine Andrew made a substan

    6/22/24 8:00:00 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    What Does the Recent Purchase at Fresh Del Monte Produce Inc. on Jun 18 Indicate?

    On June 18, 2024, an insider purchase transaction caught the attention of investors at Fresh Del Monte Produce Inc. SVP, CHRO Tenazas Marissa R made a significant move by acquiring $43,694 worth of Ordinary Shares, consisting of 2,000 units at $21.85 per unit. This purchase translated into a remarkable increase in direct ownership by 1,852% for Tenazas Marissa R, bringing her total holdings to 2,108 units, as disclosed in the SEC Form 4 filing. This substantial increase in ownership might signal confidence in the company's future prospects and potentially hint at positive developments within Fresh Del Monte Produce Inc. The timing of this insider purchase is particularly interesting when vi

    6/18/24 10:07:21 PM ET
    $FDP
    Farming/Seeds/Milling
    Consumer Staples

    $AIZ
    $ALDX
    $APO
    $ASTE
    Financials

    Live finance-specific insights

    View All

    Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%

    HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announces the presentation of a new health economics study evaluating the economic impact of earlier detection and therapeutic management of LM using the CNSide cerebrospinal fluid (CSF) assay. The cost-of-care analysis suggests that earlier LM diagnosis and therapeutic management enabled by CNSide may reduce overall LM-related healthcare costs by approximately 40%, primarily through earlier therapeutic intervention, improved treatment precisio

    3/19/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    SiteOne Landscape Supply Acquires Reinders

    SiteOne® Landscape Supply, Inc. (NYSE:SITE) announced today that it has completed the acquisition of Reinders, a leading fifth-generation, family-owned distributor of irrigation, agronomics, holiday and landscape lighting, and landscape supplies with 12 locations across Wisconsin, Michigan, Illinois, Indiana, Kansas and Minnesota. With over 150 years of industry leadership, Reinders is known for its technical expertise, rapid on-site diagnostics, tailored product recommendations and industry-leading service from a team of highly trained professionals. "As a very successful fifth-generation, family-owned company, Reinders is well-known and respected in the green industry for quality and

    3/17/26 8:00:00 AM ET
    $SITE
    Professional and commerical equipment
    Consumer Discretionary

    Bally's Corporation Announces Preliminary Fourth Quarter and Full Year 2025 Results

    Bally's Corporation ((", Bally', s", , NYSE:BALY) today reported preliminary financial results for the fourth quarter and full year ended December 31, 2025. Preliminary Fourth Quarter 2025 Results and Recent Operating Highlights Company-wide revenue of $746.2 million increased 28.6% year over year Casinos & Resorts revenue of $366.2 million increased 12.9% year over year with results benefiting from The Queen Casino & Entertainment ("Queen") transaction completed in February 2025 Bally's Intralot B2C revenue of $236.5 million, up 13.9% year over year driven by growth in UK and Spain, as well as the addition of Intralot's B2C business North America Interactive revenue of $62.3

    3/16/26 4:15:00 PM ET
    $BALY
    Hotels/Resorts
    Consumer Discretionary